<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2010</study_start_year><condition>Head and Neck Cancers</condition><condition>Colorectal Adenocarcinoma</condition><condition>Head and Neck Cancer</condition><condition>Non-Hodgkin Lymphoma</condition><condition>Breast Cancer</condition><condition>Head and Neck Neoplasms</condition><disease>Colorectal Adenocarcinoma</disease><disease>Head And Neck Neoplasms</disease><disease>Head And Neck Cancer</disease><disease>Head And Neck Cancers</disease><disease>Breast Cancer</disease><disease>Non-hodgkin Lymphoma</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2088413</full_dataset_link><location>United States</location><study_start_month>3</study_start_month><repository>ECRIN MDR</repository><study_status>Terminated</study_status></additional><is_claimable>false</is_claimable><name>FNA Tumor Sampling for CD137 Modulation: A Pilot Study</name><description>The purpose of this study is to better understand the biology of the body’s immune response to monoclonal antibody therapy for cancer. Your health information will be used to identify your tissues. The tissue we obtain may be useful for research or education, resulting in new drugs, therapies or diagnostic procedures.</description><dates><creation>2010-03-15</creation></dates><accession>2088413</accession><cross_references><ClinicalTrials___gov>NCT01114256</ClinicalTrials___gov></cross_references></HashMap>